The investment will support product development and regulatory navigation for the public cardiac arrest solution.
"We are thrilled to welcome Coblum to our portfolio. Léo is an amazingly talented and hardworking founder who has identified a massive unmet need in emergency care. By making mechanical CPR accessible to the public, Coblum has the potential to significantly improve survival rates for out-of-hospital cardiac arrests. This investment reflects our commitment to backing high-impact innovations that tackle real-world problems, and we look forward to supporting the team through their next phase of growth."
